TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth.
Despite remarkable advances in the therapy and prevention of prostate cancer it is still the second cause of death from cancer in industrialized countries. Many therapies initially shown to be beneficial for the patients were abandoned due to the high drug resistance and the evolution rate of the tu...
Guardado en:
Autores principales: | V'yacheslav Lehen'kyi, Maylis Raphaël, Agathe Oulidi, Matthieu Flourakis, Sergii Khalimonchyk, Artem Kondratskyi, Dmitri V Gordienko, Brigitte Mauroy, Jean-Lois Bonnal, Roman Skryma, Natalia Prevarskaya |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/179e9fe891d94c3cb6e0b525824e4109 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion.
por: Agathe Oulidi, et al.
Publicado: (2013) -
TRPV4 Mechanotransduction in Fibrosis
por: Ravi K. Adapala, et al.
Publicado: (2021) -
Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension
por: Brett A. McCray, et al.
Publicado: (2021) -
Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4
por: Hsueh-Hui Yang, et al.
Publicado: (2021) -
Parallel selection on TRPV6 in human populations.
por: David A Hughes, et al.
Publicado: (2008)